Charles Schwab’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Charles Schwab’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-85,386	Closed	-$3.52M	–	3123
2015 Q2	$3.52M	Buy	85,386 +12,902	+18%	+$463K	﹤0.01%	1776
2015 Q1	$2.56M	Buy	72,484 +3,394	+5%	+$115K	﹤0.01%	1920
2014 Q4	$2.22M	Sell	69,090 -2,045	-3%	-$59.1K	﹤0.01%	1948
2014 Q3	$2M	Buy	71,135 +1,463	+2%	+$44.6K	﹤0.01%	1972
2014 Q2	$2.11M	Sell	69,672 -260	-0.4%	-$7.18K	﹤0.01%	1960
2014 Q1	$1.94M	Buy	69,932 +6,218	+10%	+$163K	﹤0.01%	1974
2013 Q4	$1.63M	Buy	63,714 +5,906	+10%	+$182K	﹤0.01%	2037
2013 Q3	$1.7M	Buy	57,808 +1,562	+3%	+$43.4K	﹤0.01%	1939
2013 Q2	$1.67M	Buy	+56,246	New	+$1.55M	﹤0.01%	1870

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Charles Schwab's BRLI Position: Q3 2015 in Review

Charles Schwab sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 85,386 shares — an estimated $3.52M sold.

Charles Schwab first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $3.52M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Charles Schwab reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Charles Schwab sold 85,386 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $3.52M.
Charles Schwab first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Charles Schwab's BIO-REFERENCE LABS INC-NEW- position peaked at $3.52M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Charles Schwab's 13F filing for Q3 2015, filed 13 Nov 2015.